EMEA-000827-PIP03-11

  • Email
  • Help

Overview

Product details for Cayston
Invented nameCayston
Active substance

aztreonam

Decision numberP/0026/2013
PIP numberEMEA-000827-PIP03-11
Pharmaceutical form(s)Powder and solvent for nebuliser solution
Condition(s)/indication(s)

Treatment of Gram-negative endobronchial infection in bronchiectasis patients

Route(s) of administrationInhalation use
PIP applicant

Gilead Sciences International Ltd
E-mail: regulatory.pip@gilead.com
Country: United Kingdom
Tel. +44 (0)1223 897300
Fax +44 (0)1223 897284

Decision typeW: decision granting a waiver in all age groups for all conditions/indications

Decision